Glenmede Trust’s Cavium, Inc. CAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-250
Closed -$22K 1999
2018
Q2
$22K Sell
250
-200
-44% -$16K ﹤0.01% 1699
2018
Q1
$37K Hold
450
﹤0.01% 1747
2017
Q4
$37K Buy
+450
New +$34.8K ﹤0.01% 1747
2016
Q2
Sell
-510
Closed -$31K 2883
2016
Q1
$31K Sell
510
-105
-17% -$6.06K ﹤0.01% 1676
2015
Q4
$40K Hold
615
﹤0.01% 1646
2015
Q3
$37K Buy
615
+150
+32% +$10K ﹤0.01% 1692
2015
Q2
$31K Buy
+465
New +$32.6K ﹤0.01% 1773
2013
Q4
Sell
-575
Closed -$23K 2427
2013
Q3
$23K Buy
575
+65
+13% +$2.45K ﹤0.01% 1778
2013
Q2
$18K Buy
+510
New +$17K ﹤0.01% 1757

Glenmede Trust's CAVM Position: Q3 2018 in Review

Glenmede Trust sold out of Cavium, Inc. (CAVM) in Q3 2018, closing a stake of 250 shares — an estimated $22K sold.

Glenmede Trust first reported a position in CAVM in Q2 2013 and held it in 9 quarters. The position peaked at $40K in Q4 2015. 0 funds tracked by Wall St. Rank hold CAVM as of Q3 2018.

  • Glenmede Trust reported no remaining Cavium, Inc. position as of Q3 2018 after selling out during the quarter.
  • Glenmede Trust sold 250 Cavium, Inc. shares in Q3 2018, an estimated $22K.
  • Glenmede Trust first reported a position in Cavium, Inc. in Q2 2013 and held it in 9 quarters.
  • Glenmede Trust's Cavium, Inc. position peaked at $40K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2018.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.